Bojana Mirkovic
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo.
Journal: Oncotarget
Published: April 03, 2017
Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion.
Journal: Biological chemistry
Published: September 01, 2015
Molecular dynamics to enhance structure-based virtual screening on cathepsin B.
Journal: Journal of computer-aided molecular design
Published: January 18, 2015
Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity.
Journal: Oncotarget
Published: November 01, 2014
The current stage of cathepsin B inhibitors as potential anticancer agents.
Journal: Future medicinal chemistry
Published: August 28, 2014
Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.
Journal: Journal of medicinal chemistry
Published: December 21, 2012
Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes.
Journal: European journal of immunology
Published: April 15, 2012
Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells.
Journal: European journal of cell biology
Published: November 04, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026